• About us
  • Team
  • Privacy Policy
  • Contact
Tuesday, November 17, 2026
  • Login
No Result
View All Result
World's first weekly chronicle of development news
  • Blitz Highlights
    • Special
    • Spotlight
    • Insight
    • Entertainment
    • Sports
  • Opinion
  • Legal
  • Perspective
  • Nation
    • East
    • West
    • North
    • South
  • Business & Economy
  • World
  • Hindi Edition
  • International Editions
    • Dubai
    • Tanzania
    • United Kingdom
    • USA
  • Blitz India Business
  • Blitz Highlights
    • Special
    • Spotlight
    • Insight
    • Entertainment
    • Sports
  • Opinion
  • Legal
  • Perspective
  • Nation
    • East
    • West
    • North
    • South
  • Business & Economy
  • World
  • Hindi Edition
  • International Editions
    • Dubai
    • Tanzania
    • United Kingdom
    • USA
  • Blitz India Business
No Result
View All Result
World's first weekly chronicle of development news
No Result
View All Result

Indian-origin scientist finds cancer therapy safe for patients with HIV & TB

by Blitz India Media
October 1, 2024
in News
0
Indian-origin scientist finds cancer therapy
Blitz Bureau

NEW DELHI: In a significant breakthrough to help patients battling both HIV and tuberculosis (TB), a study led by an Indian-origin scientist found a cancer therapy that can help control TB “This is an important hurdle that this host-directed therapy had to clear in order to help patients battling both HIV and TB,” said Professor Smriti Mehra, from Texas Biomedical Research Institute (Texas Biomed)

In the study, published in the peer-reviewed journal JCI Insight, the Smriti and her team focussed on the protein, called IDO (short for Indoleamine-2,3-dioxygenase) — a therapy currently used in cancer.

While many cases of TB can be controlled with months of antibiotics, the infection can return in people who are immunocompromised as a result of HIV. A resurging TB infection — responsible for more than 1.3 million deaths worldwide — can often be deadly to these individuals.

The host-directed therapy, already approved by the US FDA, blocks or inhibits an immune system protein naturally found in the body. The team showed that IDO normally suppresses the immune system, preventing it from causing excessive inflammation and organ damage.

Blocking IDO for short intervals led to more successful cancer treatments.
Smriti’s team previously showed that the same approach improves control of TB in conjunction with antibiotics.
They experimented with the therapy in the current study in nonhuman primates with both TB and simian immunodeficiency virus — the nonhuman primate version of HIV.

The results showed the IDO inhibitor does not interfere with cART and is safe for patients with HIV. Animals given cART and the IDO inhibitor showed no “increase in viral load” compared to those with only cART. Smriti also called for longer-term studies to confirm there are no unintended side effects.

Related Posts

petrol diesel price
News

Fuel price spike pushes wholesale inflation to 12.29pc

November 16, 2026
medical supplies
News

India accelerates fight against TB, deaths drop 38pc

November 14, 2026
Power to Empower
News

Modi heads to Manila for key ASEAN, East Asia summits

November 13, 2026
India, South Africa discuss ways to enhance bilateral cooperation
News

India, South Africa discuss ways to enhance bilateral cooperation

November 12, 2026
Kidambi Srikanth China Masters quarter-finals
News

Srikanth beats World No. 8 Naraoka in Japan Masters

November 12, 2026
Real Estate Investment
News

India’s commercial real estate investment rises 15 pc in Jan-Sep

November 12, 2026
Load More
Next Post
polling

Voter queues seen at polling stations for third & final phase of J&K election

Recent News

petrol diesel price
News

Fuel price spike pushes wholesale inflation to 12.29pc

by Blitz India Media
November 16, 2026
0

New Delhi, 16 November: Wholesale inflation rose to 12.29% in October from 11.39% in September, provisional data released by the...

Read moreDetails
medical supplies

India accelerates fight against TB, deaths drop 38pc

November 14, 2026
Power to Empower

Modi heads to Manila for key ASEAN, East Asia summits

November 13, 2026
India, South Africa discuss ways to enhance bilateral cooperation

India, South Africa discuss ways to enhance bilateral cooperation

November 12, 2026
Kidambi Srikanth China Masters quarter-finals

Srikanth beats World No. 8 Naraoka in Japan Masters

November 12, 2026

Blitz Highlights

  • Special
  • Spotlight
  • Insight
  • Entertainment
  • Health

International Editions

  • US (New York)
  • UK (London)
  • Middle East (Dubai)
  • Tanzania (Africa)

Nation

  • East
  • West
  • South
  • North
  • Hindi Edition

E-paper

  • India
  • Hindi E-paper
  • Dubai E-Paper
  • USA E-Paper
  • UK-Epaper
  • Tanzania E-paper

Useful Links

  • About us
  • Team
  • Privacy Policy
  • Contact

©2024 Blitz India Media -Building A New Nation

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

    No Result
    View All Result
    • Blitz Highlights
      • Special
      • Spotlight
      • Insight
      • Entertainment
      • Sports
    • Opinion
    • Legal
    • Perspective
    • Nation
      • East
      • West
      • North
      • South
    • Business & Economy
    • World
    • Hindi Edition
    • International Editions
      • Dubai
      • Tanzania
      • United Kingdom
      • USA
    • Blitz India Business

    ©2024 Blitz India Media -Building A New Nation